PROTA THERAPEUTICS

Active specific immunotherapy agents for the treatment of allergic and intolerance disorders; antigens for the prevention and treatment of allergic and intolerance disorders; probiotic bacterial formulations for medical use; probiotic bacterial preparations for medical use; pharmaceutical preparations for oral use, namely, oral immunotherapy preparations for prevention and treatment of allergic and intolerance conditions; medical preparations for modifying allergic and intolerance conditions, namely, conditions affecting the gastrointestinal tract, skin, airways and/or lungs; pharmaceutical preparations for the treatment of food allergies or intolerances, and other allergic and intolerance conditions, namely, of the gastrointestinal tract, skin, airways and/or lungs, all of the foregoing for oral administration only

Treatment of allergies; medical services; medical treatment and advisory services; medical testing and analysis services for the diagnosis of allergic and intolerance disorders; medical diagnostic services, namely, for the diagnosis of allergic and intolerance disorders; provision of pharmaceutical information, namely, pharmaceutical information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals